Dosimetry for targeted radionuclide therapy in routine clinical practice: experts advice vs. clinical evidence
Eur J Nucl Med Mol Imaging
.
2024 Mar;51(4):947-950.
doi: 10.1007/s00259-023-06568-8.
Authors
Arnaud Dieudonné
1
2
,
Clément Bailly
3
,
Florent Cachin
4
,
Agathe Edet-Sanson
5
,
Françoise Kraeber-Bodéré
3
,
Sébastien Hapdey
5
,
Charles Merlin
4
,
Philippe Robin
6
,
Pierre-Yves Salaun
6
,
Paul Schwartz
7
,
David Tonnelet
5
,
Pierre Vera
5
,
Frédéric Courbon
8
,
Thomas Carlier
3
Affiliations
1
Department of Nuclear Medicine, Henri Becquerel Cancer Center, Rouen, France. arnaud.dieudonne@me.com.
2
Service de Médecine Nucléaire, Centre Henri Becquerel, 76000, Rouen, France. arnaud.dieudonne@me.com.
3
Department of Nuclear Medicine, University Hospital, Nantes, France.
4
Department of Nuclear Medicine, Jean Perrin Cancer Center, Clermont-Ferrand, France.
5
Department of Nuclear Medicine, Henri Becquerel Cancer Center, Rouen, France.
6
Department of Nuclear Medicine, University Hospital, Brest, France.
7
Department of Nuclear Medicine, University Hospital, Bordeaux, France.
8
Department of Medical Imaging, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France.
PMID:
38110711
PMCID:
PMC10881593
DOI:
10.1007/s00259-023-06568-8
No abstract available
Publication types
Editorial
MeSH terms
Humans
Radioisotopes* / therapeutic use
Radiometry*
Substances
Radioisotopes